Stay updated on Pembrolizumab & Enfortumab in Rare Kidney Cancers Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Enfortumab in Rare Kidney Cancers Clinical Trial page.

Latest updates to the Pembrolizumab & Enfortumab in Rare Kidney Cancers Clinical Trial page
- Check3 days agoChange DetectedThe homepage text updates the total number of studies from 598,690 to 599,765, reflecting a refreshed database size across all 50 states and 226 countries.SummaryDifference0.1%

- Check10 days agoChange DetectedThe homepage stat about the total number of studies has been updated to 598,690, replacing the previous figure of 597,691 to reflect the current dataset size.SummaryDifference0.1%

- Check17 days agoChange DetectedOn the homepage, the total number of studies listed increases from 596,690 to 597,691, reflecting a larger database. The revision/version label also updates from v3.6.4 to v3.6.5.SummaryDifference0.3%

- Check24 days agoChange DetectedThe homepage statistic for total studies updated from 595,630 to 596,690, reflecting a larger registry of trials across the United States and internationally.SummaryDifference0.1%

- Check31 days agoChange DetectedThe homepage’s total study count updated from 594,543 to 595,630, and the site revision tag updated from v3.6.3 to v3.6.4. This reflects a new release and the current scope of studies displayed.SummaryDifference0.3%

- Check38 days agoChange DetectedThe homepage now displays the updated total number of studies (594,543) instead of the previous figure (593,334). This reflects current data on registered studies and provides users with a refreshed sense of the database size.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab & Enfortumab in Rare Kidney Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Enfortumab in Rare Kidney Cancers Clinical Trial page.